Drug Therapy
Conference Coverage
GALILEO, GALILEO 4D: Mixed results in post-TAVR anticoagulation
Conference Coverage
DAPA-HF: Dapagliflozin’s HFrEF efficacy confirmed in nondiabetics
PHILADELPHIA –
News
FDA panel supports Vascepa expanded indication for CVD reduction
Icosapent ethyl (Vascepa), purified eicosapentaenoic acid, got unanimous support from an FDA panel for a new indication of reducing CVD events.
FDA/CDC
CDC releases update of 2013 Antibiotic Resistance Threats Report
The report includes the hopeful news that there were 42 new antibiotics in development as of June 2019.
Conference Coverage
Opioid reduction works after minimally invasive gynecologic surgery
VANCOUVER – Two randomized trials show a reduction in prescribed opiates decreases postoperative usage with no loss...
Latest News
ACP recommends ways to address rising drug prices
One of the College’s suggestions is for the Medicare Part D low-income subsidy program to be modified.
Conference Coverage
MS-related disability may be decreasing
STOCKHOLM – International data indicate that the prognosis of MS has improved, partly as a result of treatment.
Conference Coverage
Benefits of BGF triple fixed-dose therapy consistent in COPD patients without exacerbation history
NEW ORLEANS – Findings were similar to overall results of KRONOS, suggesting exacerbation history did not drive...
Article
How to use type 2 diabetes meds to lower CV disease risk
The challenge: Translate evidence from cardiovascular outcomes trials of newer antidiabetic agents into a targeted management strategy.
Conference Coverage
Get ready for changes in polypharmacy quality ratings
NATIONAL HARBOR, MD. – A new rating system will replace the current high-risk medication measurement that is being retired this year.